SCHEMBL4331000

SCHEMBL4331000

COC(=O)c1ccc2oc(C(=O)Nc3ccc(Cl)cn3)c(N)c2c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.55
▸ ALDH1A1 P00352 4/20 0.47
▸ RAB9A P51151 9/20 0.46
▸ NPC1 O15118 7/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ ALOX15 P16050 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ KMT2A Q03164 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ TP53 P04637 3/20 0.45
▸ TSHR P16473 2/20 0.45
▸ NFKB1 P19838 2/20 0.45
▸ NFKB2 Q00653 2/20 0.45
▸ RELA Q04206 2/20 0.45
▸ CYP2C19 P33261 2/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ SORT1 Q99523 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2941909 0.87 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2944785 0.81 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2949845 0.80 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2948943 0.80 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2945609 0.80 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2949746 0.79 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2946682 0.78 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL13291230 0.78 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2947441 0.78 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E
SCHEMBL2945014 0.77 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
CN-100430392-C Carbamoyl-type benzofuran derivatives TANABE SEIYAKU CO (JP) 2008-11-05 — — CN disclosed
US-20060247273-A1 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-11-02 — — US disclosed
CN-1856488-A Carbamoyl-type benzofuran derivatives TANABE SEIYAKU CO (JP) 2006-11-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247273-A1 Carbamoyl-type benzofuran derivatives F12, F2, F3 SMN1; SMN2 4587/4885ALDH1A1 1153/4885RAB9A 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback